Liangzi Guo; Jun He; Sai Hou; Ziqing Yuan; Junling Yu; Zhaoqian Meng; Guoxia Guo; Xialian Gao; Huaibiao Li; Lei Gong; Yinxu Hou; Jialin Zhang; Xiuzhi Chen; Yujie Feng; Xiaofeng Lyu; Tuantuan Li; Ge Bu; Jiabing Wu; Liangzi Guo; Jun He; Sai Hou; Ziqing Yuan; Junling Yu; Zhaoqian Meng; Guoxia Guo; Xialian Gao; Huaibiao Li; Lei Gong; Yinxu Hou; Jialin Zhang; Xiuzhi Chen; Yujie Feng; Xiaofeng Lyu; Tuantuan Li; Ge Bu; Jiabing Wu

doi:10.46234/ccdcw2025.261

[1]

Shiferaw B, Lam P, Tuthill S, Choudhry H, Syed S, Ahmed S, et al. The Chikungunya epidemic: a look at five cases. IDCases 2015;2(4):89 − 91. https://doi.org/10.1016/j.idcr.2015.08.004.

[2]

Webb E, Michelen M, Rigby I, Dagens A, Dahmash D, Cheng V, et al. An evaluation of global Chikungunya clinical management guidelines: a systematic review. eClinicalMedicine 2022;54:101672. https://doi.org/10.1016/j.eclinm.2022.101672.

[3]

Calvez E, Bounmany P, Somlor S, Xaybounsou T, Viengphouthong S, Keosenhom S, et al. Multiple Chikungunya virus introductions in Lao PDR from 2014 to 2020. PLoS One 2022;17(7):e0271439. https://doi.org/10.1371/journal.pone.0271439.

[4]

World Health Organization. Disease outbreak news; Chikungunya virus disease-global situation. 2025. https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON581. [2025-10-3].

[5]

Li YH, Jiang SY, Zhang M, Li Y, He JF, Yang ZF, et al. An outbreak of Chikungunya fever in China - Foshan City, Guangdong Province, China, July 2025. China CDC Wkly 2025;7(32):1064 − 5. https://doi.org/10.46234/ccdcw2025.172.

[6]

Guangdong Provincial Center for Disease Control and Prevention. Guangdong Province Chikungunya fever surveillance information (August 3-9, 2025). 2025. https://cdcp.gd.gov.cn/ywdt/zdzt/yfjkkyr/yqxx/content/post_4756601.html. [2025-8-18]. (In Chinese).

[7]

Chen LH, Fritzer A, Hochreiter R, Dubischar K, Meyer S. From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated Chikungunya vaccine. J Travel Med 2024;31(7):taae123. https://doi.org/10.1093/jtm/taae123.

[8]

Zhao J, Liu RC, Chen SL, Chen TM. A model for evaluation of key measures for control of Chikungunya fever outbreak in China. Chin J Epidemiol 2015;36(11):1253 − 7. https://doi.org/10.3760/cma.j.issn.0254-6450.2015.11.014.

[9]

Lin BL, Xie DY, Zhai JQ, Huang YB, Gao ZL. Investigation of confirmed cases with Chikungunya fever in Dongguan. J Sun Yat-Sen Univ (Med Sci) 2011;32(2):208 − 12. https://doi.org/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2011.0038.

[10]

Zhai JQ, Li HC, Lin BL, Chen GX, Huang YB, Yin SC. Clinical features of inpatients in the first Chikungunya fever epidemic in China. Chin J Infect Dis 2011;29(6):344 − 7. https://doi.org/10.3760/cma.j.issn.1000-6680.2011.06.007.

[11]

Shan YY, Chen YS, Huang JM, Wu B. The first imported case of Chikungunya fever reported in Haikou City, Hainan Province. China Trop Med 2025;1-5. https://link.cnki.net/urlid/46.1064.R.20250814.1138.002. [2025-11-27]. (In Chinese).

[12]

Ning XH, Yu CY, Cheng ZM, Gao R, Tang HL, Xia BH, et al. Genotype distribution and transmission risk of Chikungunya virus detected in China. Chin J Vector Biol Control 2025;36(5):557 − 67. https://doi.org/10.11853/j.issn.1003.8280.2025.05.001.

[13]

Borgherini G, Poubeau P, Staikowsky F, Lory M, Moullec NL, Becquart JP, et al. Outbreak of Chikungunya on reunion island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007;44(11):1401 − 7. https://doi.org/10.1086/517537.

[14]

Zhang M, Chen PH, Huang ZY, Zhong XG, Chen WF, Zeng YM, et al. Clinical characteristics of 81 laboratory-confirmed Chikungunya fever cases. Chin J Clin Infect Dis 2011;4(4):239 − 41. https://doi.org/10.3760/cma.j.issn.1674-2397.2011.04.013.

[15]

Danis-Lozano R, Díaz-González EE, del Carmen Trujillo-Murillo K, Caballero-Sosa S, Sepúlveda-Delgado J, Malo-García IR, et al. Clinical characterization of acute and convalescent illness of confirmed Chikungunya cases from Chiapas, S. Mexico: a cross sectional study. PLoS One 2017;12(10):e0186923. https://doi.org/10.1371/journal.pone.0186923.

[16]

Chua CL, Sam IC, Chiam CW, Chan YF. The neutralizing role of IgM during early Chikungunya virus infection. PLoS One 2017;12(2):e0171989. https://doi.org/10.1371/journal.pone.0171989.

[17]

Chelluboina S, Robin S, Aswathyraj S, Arunkumar G. Persistence of antibody response in Chikungunya. VirusDisease 2019;30(3):469 − 73. https://doi.org/10.1007/s13337-019-00534-5.

[18]

Wan SC, Zhang X, Cong X, Liu Y, Huang S, Zhou MY, et al. Viral load dynamics of chikungunya virus in human specimens - Foshan City, Guangdong Province, China, 2025. China CDC Wkly 2025;7(33):1067 − 72. https://doi.org/10.46234/ccdcw2025.182.

[19]

Prince HE, Seaton BL, Matud JL, Batterman HJ. Chikungunya virus RNA and antibody testing at a national reference laboratory since the emergence of Chikungunya virus in the Americas. Clin Vaccine Immunol 2015;22(3):291 − 7. https://doi.org/10.1128/CVI.00720-14.